Tightly regulated ion homeostasis throughout the body is necessary for the prevention of such debilitating states as dehydration.
time changes in sodium concentrations in vivo when injected subcutaneously into mice. 3 Herein, we explain in detail and demonstrate the methodology for fabricating fluorescent sodium nanosensors and briefly demonstrate the biological applications our lab uses the nanosensors for: the microinjection of the sensors into cells; and the subcutaneous injection of the sensors into mice.
Video Link
The video component of this article can be found at http://www.jove.com/video/2896/ Protocol
Preparation of optode
Before making the optode, aliquots of the components are need so that they can be easily measured and stored.
1. A 50 mg Sodium Ionophore X (NaIX) vial and a 50 mg sodium tetrakis [3,5-bis(trifluoromethyl) phenyl]borate (NaTFPB) will each be brought up in tetrahyrdofuran (THF) and aliquoted into 1.5 ml polystyrene centrifuge tubes. In a chemical fume hood, dissolve the 50 mg of NaIX in 1 ml of THF in the shipping vial and mix to ensure that the solid has completely dissolved. Transfer 100 μl of this solution into 10 separate centrifuge tubes. Repeat for NaTFPB. Allow the THF to evaporate in a chemical fume hood overnight, label the centrifuge tubes and place them in a 4 degree refrigerator for storage. This creates 5 mg aliquots of dry NaIX and NaTFPB. 2. Dissolve the Chromoionophore III (CHIII) in 1 ml of THF and transfer to a 3 ml glass vial. Add another 1 ml of THF to the CHIII shipping vial to dissolve any residual CHIII and add this to the 3 ml glass vial. There will be a total of 2 ml now. Transfer 1 ml of the CHIII in THF solution to two separate 1.5 ml glass vials with a Teflon coated caps. Store the CHIII solution in a 4 degree refrigerator at the final concentration of 5 mg/ ml.
These aliquots and solutions will be used to make the optode material.
3. Pipette 66 μl of bis(2-ethylhexyl)sebacate (DOS) into a 1.5 ml glass vial with a Teflon coated screw cap -this is the optode vial. DOS is a viscous solution so care must be taken to ensure the proper amount of solution is transferred to the vial. The volume corresponds to ˜ 60 mg of DOS. 4. Weigh out 30 mg of high molecular weight poly(vinyl) chloride (PVC) and transfer this to the optode vial. 5. Now add the aliquoted functional components to the optode vial to create the desired optode. The relative concentrations of CHIII, NaIX, and NaTFPB will determine the response of the sensor to sodium. These concentrations can be adjusted to have a sensor that ideally responds to intracellular concentrations, with a Kd of 10 mM, or extracellular concentrations, with a Kd of 150 mM. Additionally, there will likely be Here we describe the method to create a sensor with concentrations that are typically used for intracellular sodium measurements. 6. In a chemical fume hood, transfer 100 μl of the 5 mg/ml CHIII in THF solution to the optode vial. 7. Dissolve 5 mg of NaIX in 300 μl of THF and transfer 300 μl to the optode vial, this correlates to 5 mg of NaIX. 8. Dissolve a 5 mg aliquot of the NaTFPB in 500 μl of THF and transfer 20 μl of the solution to the optode vial, this correlates to 0.1 mg of NaTFPB. 9. Add 80 μl of THF to the optode vial. 10. The solution in the optode vial contains 30 mg of PVC, 60 mg of DOS, 5 mg of NaIX, 0.2 mg of NaTFPB, 0.5 mg of CHIII in 500 μl of THF.
Gently vortex this vial until all of the PVC has dissolved. The optode should be a red color. The total amount of THF added to the vial should be 500 μL regardless of the ratio of components used. 11. Allow the remaining THF in the NaIX and NaTFPB aliquots to evaporate overnight and re-label the tube with the correct amount of chemical.
Creating nanosensors
1. Pipette 100 μl of 10 mg/ml 1,
into a 4 dram glass vial. Allow the chloroform to evaporate in a chemical fume hood. This process can be expedited by drying the solution with nitrogen gas or house air. 2. Add 4 ml of the desired aqueous solution to the vial with PEG-lipid. Place the vial on a laboratory jack underneath the sonicating tip and raise the vial until the tip is about 7 mm deep in the solution and sonicate at a low sonication power for 30 seconds. Here we use a Branson digital sonifier set to 15% amplitude with a ½ inch tip diameter step horn. The aqueous solution can be any solution. For example, to determine the response of the sensors we use 10 mM HEPES pH 7.2 with trizma base. 3. While the solution is being sonicated, mix 50 μl of the optode material with 50 μl of dichloromethane in a 0.6 ml microcentrifuge tube. Mix with the pipette to ensure even mixing. 4. Adjust the sonifier control to sonicate for 3 minutes. Start the sonication and while sonicating add the optode mixture solution to the vial by immersing the pipette tip into the solution and dispensing the 100 μl of solution in one quick, even injection. The solution should turn blue, depending on the aqueous solution used. 5. Allow the sonication to continue for about 30 seconds then lower the jack so that the sonicating tip is about 2 mm deep in solution. This should begin to aerate the solution and the solution will become opaque. This step helps to remove the residual THF and dichloromethane from the solution. 6. Once sonication is complete, pull up the nanosensor solution into a 5 ml syringe. Attach a 0.2 μm syringe filter and dispense the nanosensor solution into a glass vial with screw top cap. The solution should be clear and blue if an aqueous solution that contains less than 10 mM sodium and has a pH less than about 9 is used. Otherwise, it should have no color or be pink.
Determining nanonsensor response
This method is used to determine the response of nanosensors designed to measure intracellular sodium. Different concentrations are recommended to be used for extracellular sodium concentration nanosensors.
1. Make stock solutions of 10 mM HEPES (0 Na) and 1M sodium chloride (NaCl) in 10 mM HEPES (1 M Na) and pH each of these solutions to 7.2 using trizma base. Mix stock solutions of 0 Na and 1 M Na in 50 ml conical centrifuge tubes to create solutions with: 0, 1, 5, 10, 20, 50, 100, 200, 500, 1000 mM NaCl concentrations. 2. Use an optical bottom 96 well plate to determine the response. Add 100 μl of each concentration of sodium to 3 wells in a column. This will produce an array of 3 x 10 wells. 3. To each well add 100 μl of freshly prepared nanosensors and load into a microplate fluorometer. We use a Molecular Devices Spectramax M3. The nanosensor intensity at each wavelength is dependent on the sodium concentration. The use of the wavelength depends on the applications. For intracellular slow dynamics measurements, we use 488 nm/570 nm (excitation/emission) and 488 nm/670 nm which allow us to ratio the two wavelengths and reduce noise.
5. Traditionally, optode data is converted to a values which are: α = (I -I min )/(I max -I min ), where I is the intensity at a given sodium concentration, I min is the lowest intensity in the response measurements, and I max is the highest intensity in the response measurements. Convert either the ratio of intensity at 570 nm divided by the intensity at 670 nm or the intensity at 680 nm to α. 6. Use plotting software, either Excel or Origin are typically used in our lab, to plot α versus the log of the sodium concentration, setting the log of zero sodium concentration to -1. Fit a sigmoidal curve to the response. From the curve, calculate the sodium concentration at α = 0.5 which represents the concentration at which the sensor optimally responds. 7. Adjust the ratio of CHIII, NaIX, and NaTFPB in the optode to create nanosensors with optimal response around the sodium concentration of interest.
In vivo imaging
All procedures have been reviewed and approved by Northeastern University's Animal Care and Use Committee.
1. Nanosensors for in vivo, extracellular imaging are made in phosphate buffered saline and adjusted to have an optimal response to sodium at a sodium concentration of 135 mM. 2. For the injection set-up and imaging of the fluorescent nanosensors in mice, we use the IVIS Lumina II and its associated anesthesia unit.
Disinfect the induction and imaging chambers. Place CD1 nude mice (approximately 20g) in the induction chamber and expose them to isoflurane. The percent of isoflurane and oxygen flowrate administered will vary depending on the species and weight of mice. Wait for the mice to become fully anesthetized. 3. After the mice are anesthetized, remove the mice from the induction chamber and place into the imaging chamber. Keep the mice under anesthesia. For each mouse, disinfect the desired injection areas. 4. Fill a sterile 31G insulin syringe with 10 μL of nanosensors making sure to remove all air bubbles. 5. Using forceps, grasp a small fold of skin along the back of the mouse at the desired injection site. While grasping the skin, insert the syringe into the skin with the bevel facing up and the needle parallel to the skin. 6. Prior to injecting the sensors, pull back on the syringe plunger to ensure the needle is not inserted into a blood vessel. Then, gently move the needle right and left to create a pocket within the skin. This will minimize the back pressure which causes the sensors to leak out of the injection site. Inject the sensors and gently remove the syringe. 7. Gently apply pressure to the injection site and wipe away any solution that may have leaked out of the injection site. This will minimize fluorescence from sensors that are not injected into the skin. 8. Repeats steps 5.4 through 5.7 until the number of desired injection areas is reached. Six injection sites evenly spaced on the left and right side of the back are recommended. For each individual mouse, change needles if the needle becomes difficult to insert into the skin. Needles should not be shared between mice. This will minimize disease transmission or cross-contamination amongst mice. 9. For imaging the sodium fluorescent sensors, we acquire both brightfield and fluorescent images of the mice using filter sets that most closely matched the 640 nm/680 nm (excitation/emission) spectrum of the nanosensors and that also minimize the autofluorescence of the skin.
Representative Results

Figure 1.
Response curves of five different nanosensor sets to sodium. Each set represents nanosensors from different optode formulations that had the same amount of CHIII, NaTFPB, PVC and DOS but varying amounts of NaIX . The data were converted to α values using the 639/680 
Discussion
The formation of nanosensors should take no longer than 10 minutes once the optode solution has been made and the PEG lipid dried. Optode can not only be made quickly when needed, but when stored at 4 degrees Celsius, they can be stable for months. We have shown that the nansensors, once formed, are stable in solution for at least a week; however, care must be taken to prevent photobleaching over this time by blocking the nanosensors from light. 6 While sodium nanosensors were demonstrated here, optodes have been created for most biologically relevant ions such as potassium and chloride. 10, 12 We have also extended this technology to small molecules such as glucose. 13 In addition to generating nanosensors to monitor different analytes, these nanosensors are amenable to other changes that will make them useful in most biological experiments. For example, the surface coating, in this case poly(ethylene glycol), can easily be changed using any amphiphilic molecule that is water soluble. This enables the possibility of functionalizing these nanoparticles for different applications or targets. The size of the nanoparticles can also be adjusted by altering the surface coating, the sonication intensity or the solvent used.
Calcium fluorescent indicators have been invaluable in determining intracellular calcium signaling; however, no available sodium sensitive dyes have the same ideal characteristics. Optode nanoparticles intended to provide an alternative method for imaging ions intracellularly have been in development for years. 14 We have built upon this previous research to create nanosensors specific for intracellular sodium imaging that will hopefully provide a means to understand how sodium signaling affects cellular function and alterations in signaling which lead to certain diseases.
The use of fluorescent nanosensors in vivo offers a real-time minimally-invasive alternative for monitoring analytes over other methods such as blood draws. 3 Sodium and glucose nanosensors based on the technology above have been shown to track changes in sodium and glucose, respectively in vivo. 3, 13 However, there currently exist limitations to this method as a monitoring tool. For example, the sensors must contain a fluorophore with a spectrum sufficiently shifted towards the near infrared red in order to minimize background autofluorescence from the skin. 15 Second, the current injection technique does not produce uniform injection of the nanosensors which may be caused by such errors as variation in injection depth. Despite these limitations, the development of these fluorescent nanosensors and their successful demonstration could make these sensors an invaluable research tool and method for monitoring patient health.
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